Sampling distributions of critical illness insurance premium rates: Breast and ovarian cancer

Li Lu, Angus Macdonald, Howard Waters

Research output: Contribution to journalArticle

Abstract

Evaluating the risk of disorders in long-term insurance often relies on rates of onset estimated from quite small epidemiological studies. These estimates can carry considerable uncertainty, hence so may functions of them, such as a premium rate. In the case of genetic disorders, where it may be required to demonstrate the reliability of genetic information as a risk factor, such uncertainty may be material. Epidemiological studies publish their results in a variety of forms and it is rarely easy to estimate the sampling distribution of a premium rate without access to the original data. We found a large study of breast and ovarian cancer that cited relative risks of breast and ovarian cancer onset, with confidence intervals, in 10-year age groups. We obtained critical illness premium rates and their sampling distributions by parametric bootstrapping, and investigated the effect of possible patterns of sampling correlations. We found that this study provides ample statistical evidence that known BRCA1 or BRCA2 mutations, or a typical family history of breast or ovarian cancer, are reliable risk factors, but the sampling covariances of the relative risks could be important at some ages and terms. Studies that cite only standard errors of parameter estimates erect a small but awkward barrier between the models they describe, and some important actuarial questions. © 2008 by Astin Bulletin. All rights reserved.

Original languageEnglish
Pages (from-to)527-542
Number of pages16
JournalASTIN Bulletin: The Journal of the IAA
Volume38
Issue number2
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Insurance
Critical Illness
Ovarian Neoplasms
Breast Neoplasms
Uncertainty
Epidemiologic Studies
Inborn Genetic Diseases
Age Groups
Confidence Intervals
Mutation

Keywords

  • Breast cancer
  • Critical illness insurance
  • Family history
  • Genetics
  • Ovarian Cancer
  • Parametric bootstrapping
  • Sampling distributions

Cite this

@article{2764fd5afcc2423283198a639ee5d5d9,
title = "Sampling distributions of critical illness insurance premium rates: Breast and ovarian cancer",
abstract = "Evaluating the risk of disorders in long-term insurance often relies on rates of onset estimated from quite small epidemiological studies. These estimates can carry considerable uncertainty, hence so may functions of them, such as a premium rate. In the case of genetic disorders, where it may be required to demonstrate the reliability of genetic information as a risk factor, such uncertainty may be material. Epidemiological studies publish their results in a variety of forms and it is rarely easy to estimate the sampling distribution of a premium rate without access to the original data. We found a large study of breast and ovarian cancer that cited relative risks of breast and ovarian cancer onset, with confidence intervals, in 10-year age groups. We obtained critical illness premium rates and their sampling distributions by parametric bootstrapping, and investigated the effect of possible patterns of sampling correlations. We found that this study provides ample statistical evidence that known BRCA1 or BRCA2 mutations, or a typical family history of breast or ovarian cancer, are reliable risk factors, but the sampling covariances of the relative risks could be important at some ages and terms. Studies that cite only standard errors of parameter estimates erect a small but awkward barrier between the models they describe, and some important actuarial questions. {\circledC} 2008 by Astin Bulletin. All rights reserved.",
keywords = "Breast cancer, Critical illness insurance, Family history, Genetics, Ovarian Cancer, Parametric bootstrapping, Sampling distributions",
author = "Li Lu and Angus Macdonald and Howard Waters",
year = "2008",
month = "11",
doi = "10.2143/AST.38.2.2033352",
language = "English",
volume = "38",
pages = "527--542",
journal = "ASTIN Bulletin: The Journal of the IAA",
issn = "0515-0361",
publisher = "Peeters Publishers",
number = "2",

}

Sampling distributions of critical illness insurance premium rates : Breast and ovarian cancer. / Lu, Li; Macdonald, Angus; Waters, Howard.

In: ASTIN Bulletin: The Journal of the IAA, Vol. 38, No. 2, 11.2008, p. 527-542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sampling distributions of critical illness insurance premium rates

T2 - Breast and ovarian cancer

AU - Lu, Li

AU - Macdonald, Angus

AU - Waters, Howard

PY - 2008/11

Y1 - 2008/11

N2 - Evaluating the risk of disorders in long-term insurance often relies on rates of onset estimated from quite small epidemiological studies. These estimates can carry considerable uncertainty, hence so may functions of them, such as a premium rate. In the case of genetic disorders, where it may be required to demonstrate the reliability of genetic information as a risk factor, such uncertainty may be material. Epidemiological studies publish their results in a variety of forms and it is rarely easy to estimate the sampling distribution of a premium rate without access to the original data. We found a large study of breast and ovarian cancer that cited relative risks of breast and ovarian cancer onset, with confidence intervals, in 10-year age groups. We obtained critical illness premium rates and their sampling distributions by parametric bootstrapping, and investigated the effect of possible patterns of sampling correlations. We found that this study provides ample statistical evidence that known BRCA1 or BRCA2 mutations, or a typical family history of breast or ovarian cancer, are reliable risk factors, but the sampling covariances of the relative risks could be important at some ages and terms. Studies that cite only standard errors of parameter estimates erect a small but awkward barrier between the models they describe, and some important actuarial questions. © 2008 by Astin Bulletin. All rights reserved.

AB - Evaluating the risk of disorders in long-term insurance often relies on rates of onset estimated from quite small epidemiological studies. These estimates can carry considerable uncertainty, hence so may functions of them, such as a premium rate. In the case of genetic disorders, where it may be required to demonstrate the reliability of genetic information as a risk factor, such uncertainty may be material. Epidemiological studies publish their results in a variety of forms and it is rarely easy to estimate the sampling distribution of a premium rate without access to the original data. We found a large study of breast and ovarian cancer that cited relative risks of breast and ovarian cancer onset, with confidence intervals, in 10-year age groups. We obtained critical illness premium rates and their sampling distributions by parametric bootstrapping, and investigated the effect of possible patterns of sampling correlations. We found that this study provides ample statistical evidence that known BRCA1 or BRCA2 mutations, or a typical family history of breast or ovarian cancer, are reliable risk factors, but the sampling covariances of the relative risks could be important at some ages and terms. Studies that cite only standard errors of parameter estimates erect a small but awkward barrier between the models they describe, and some important actuarial questions. © 2008 by Astin Bulletin. All rights reserved.

KW - Breast cancer

KW - Critical illness insurance

KW - Family history

KW - Genetics

KW - Ovarian Cancer

KW - Parametric bootstrapping

KW - Sampling distributions

UR - http://www.scopus.com/inward/record.url?scp=58049203897&partnerID=8YFLogxK

U2 - 10.2143/AST.38.2.2033352

DO - 10.2143/AST.38.2.2033352

M3 - Article

VL - 38

SP - 527

EP - 542

JO - ASTIN Bulletin: The Journal of the IAA

JF - ASTIN Bulletin: The Journal of the IAA

SN - 0515-0361

IS - 2

ER -